Trial Shows Lenacapavir + bNAbs As Possible HIV Treatment

New longer-acting treatment options for HIV may be on the horizon.

JULY 28, 2025

What Long-Acting HIV Drugs Are in the Pipeline?

Sherene Min, MD, MPH, sat down with IDSE to talk about investigational long-acting drugs in the pipeline to prevent ...

JULY 14, 2025

Key Takeaways for PrEP, HIV Treatment and Other Infectious Diseases

CROI 2025 highlighted promising therapeutic modalities for HIV treatment and prevention.

JULY 3, 2025

2 HIV Vaccine Trials Show Proof of Concept for Pathway to bnAbs

A new study shows that a targeted vaccine strategy can successfully activate early immune responses relevant to ...

JUNE 12, 2025

Investigational Combo Lenacapavir + bNAbs Would Push HIV Treatment to Twice Yearly

The investigational combination of lenacapavir with two broadly neutralizing antibodies would make twice-yearly HIV ...

FEBRUARY 23, 2023

Novel HIV Combination Therapies Could Prevent Viral Escape and Rebound

Computational approaches to selecting combinations of bNAbs based on viral genetics could help prevent viral ...

JULY 20, 2022

NIH Launches Study to Test Combination Antibody Treatment for HIV

NIAID has begun a clinical trial testing infusions of combination antibodies in people living with HIV.

SEPTEMBER 21, 2018